Target intelligence / Profile preview

Glutamate Receptor (AMPA subtype) (AMPAR)

Target
AMPAR
Molecular classification
Receptor, Ion channel, Ligand-gated ion channel
01

Overview

The AMPA receptor (α-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid receptor, also known as AMPAR or quisqualate receptor) is a type of ionotropic glutamate receptor that mediates fast excitatory neurotransmission in the central nervous system (CNS). It functions primarily as a ligand-gated cation channel, allowing the flow of sodium (Na⁺) and, depending on subunit composition, calcium (Ca²⁺) ions into postsynaptic neurons upon activation by glutamate. The AMPA receptor is a tetramer composed of four subunits: GluA1–GluA4, encoded by genes GRIA1–GRIA4. Subunit composition determines functional properties such as ion permeability and gating kinetics. AMPA receptors play essential roles in synaptic plasticity mechanisms such as long-term potentiation/depression, learning/memory formation, and general cognitive processing.

Other names
AMPA receptorα-amino-3-hydroxy-5-methylisoxazolepropionic acid receptorQuisqualate receptor
02

Mechanism of action

Agonists bind to the ligand-binding domain, opening the cation channel and allowing influx of Na+ and Ca2+ ions, leading to neuronal depolarization and excitation. Antagonists block this channel, preventing ion flow and inhibiting neuronal excitation.

03

Biological functions

Fast excitatory neurotransmissionSynaptic plasticityLearning and memoryCognitive processing
04

Disease associations

Neurodegenerative diseaseEpilepsyStrokeSchizophreniaDepressionOther
05

Safety considerations

ExcitotoxicitySeizuresNeurotoxicity
06

Interacting drugs

AMPA

4 more in the full profile.

Beyond the preview

Go deeper on Glutamate Receptor (AMPA subtype) (AMPAR).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Glutamate Receptor (AMPA subtype) (AMPAR).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call